Head of Investor Relations
Solara Active Pharma Sciences Limited
Equibles does not estimate personal net worth.
Abhishek Singhal is recorded as Head of Investor Relations at Solara Active Pharma Sciences Limited. Abhishek Singhal has spoken on 3 earnings calls across 1 company, most recently for Solara Active Pharma Sciences Limited on October 16, 2026. Solara Active Pharma Sciences Limited is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.
“Good evening and thank you all for joining us today for Solara's earnings call for the second quarter and half year ended September 30, 2026. Today we have with us Sandeep, MD, and CEO, and Sharad, CFO of the company to share the address of the business, and financials of the quarter, and H1 F527.”
“Good evening, and thank you all for joining us today for Solara, the earnings call for QNFI 27. Today we have with us Sandeep, MD and CEO, and Sharad, CFO of the company, to share the highlight of the business and financials for the quarter.”
“Good afternoon, and thank you all for joining us today for Solara earnings call for the fourth quarter in financial year, 2026. Today, we have with us Sandeep, MD and CEO, and Sharad, CFO, the company, to share the highlights of the business and financials of the quarter in financial year.”
Solara Active Pharma Sciences Limited
Head of Investor Relations
Transcript header (unverified)
Solara Active Pharma Sciences Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Head of Investor Relations
Earnings Call for the Quarter Ended September 30, 2026
Solara Active Pharma Sciences Limited
Earnings Call for the Quarter Ended June 30, 2026
Solara Active Pharma Sciences Limited
Earnings Call for the Quarter Ended March 31, 2026
Solara Active Pharma Sciences Limited
